These genes are ANKRD6, ITIH3, SORCS3, NPY1R and CCDC178, which form a signature associated to adverse clinic-pathological features such as advanced tumor stage, poor prognosis and disease recurrence in GC. This evidence concerns the gene CCDC178 and neoplasm.